Professor David Kerr, CBE, MA, MD, DSc, FRCP (Glas, Edin & Lon), FRCGP (Hon), FMedSci, President, European Society of Medical Oncology; Professor of Cancer Medicine, University of Oxford, Adjunct Professor of Medicine, Weill Cornell Medical College
Dr. Kerr is British cancer researcher with an international reputation for the treatment and research into colorectal cancer. He is a former advisor to British Prime Ministers Tony Blair and David Cameron.
Dr. Kerr is working on developing new approaches to cancer treatment that involve novel biomarkers and inhibitors of key biochemical pathways. He is currently Professor of Cancer Medicine at Oxford, where he has worked with colleagues to build a new Institute for Cancer Medicine and Cancer Hospital, and Adjunct Professor of Medicine at Weill-Cornell College of Medicine in New York.
Dr. Kerr recently returned from Qatar, where he was appointed to the Supreme Council of Health, effectively Qatar’s Health cabinet, and as Chief Research Adviser to Her Highness Sheikha Moza. The quality of his work has been recognized by the award of several international prizes and the first Nye-Bevan award for innovation from England’s National Health Service (NHS).Â He has published more than 350 articles in peer-reviewed journals (including New England Journal of Medicine, The Lancet and Nature Genetics) and has contributed to many books on cancer.Â
Dr. Kerr has made a significant contribution to reforming the NHS and developed a 20-year plan for the future of the NHS in Scotland, known as the “Kerr Report.”Â He was Editor-in-Chief of Annals of Oncology, Europe’s premier medical oncology journal Reviews Oncology (2001-2008), and is on the editorial board of several other journals.Â He has established a series of major international collaborations, establishing a trials network with India’s leading cancer center’s INDOX (http://www.indox.org.uk/) and AfrOx (http://www.afrox.org), which aims to improve the delivery of cancer care in sub-Saharan Africa. He was elected Fellow of the Academy of Medical Sciences in 2000, Honorary Fellow of Royal College of General Practitioners in 2007, appointed Commander of the British Empire in 2002, and appointed President of the European Society of Medical Oncology in 2010.